Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Austen

Showing results (381-390 of 604) with videos related to

Pageof 61
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1970
Genetic and cellular factors in the immune response. I. Genetic control of the antibody response to poly Glu52 Lys33 Tyr15 in the inbred rat strains ACI and F344T J Gill, H W Kunz, D J Stechschulte, et al.
Clinical and Experimental Immunology|April 1, 1978
Cutaneous necrotizing venulitis: a sequential analysis of the morphological alterations occurring after mast cell degranulation in a patient with a unique syndromeN A Soter, M C Mihm, H F Dvorak, et al.
The Journal of Biological Chemistry|December 25, 1980
Polydispersity of rat mast cell heparin. Implications for proteoglycan assemblyD D Metcalfe, J A Smith, K F Austen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1983
Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factorA Nicholson-Weller, J P March, S I Rosenfeld, et al.
The Journal of Biological Chemistry|November 15, 1986
Complexes of heparin proteoglycans, chondroitin sulfate E proteoglycans, and [3H]diisopropyl fluorophosphate-binding proteins are exocytosed from activated mouse bone marrow-derived mast cellsW E Serafin, H R Katz, K F Austen, et al.
The New England Journal of Medicine|March 13, 1980
Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticariaN A Soter, S I Wasserman, K F Austen, et al.
The Journal of Experimental Medicine|February 1, 1978
Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparinJ M Weiler, R W Yurt, D T Fearon, et al.
The Journal of Biological Chemistry|February 5, 1986
Inhibition of homogeneous human eosinophil arylsulfatase B by sulfidopeptide leukotrienesP F Weller, E J Corey, K F Austen, et al.
The Journal of Experimental Medicine|November 1, 1979
Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3bM D Kazatchkine, D T Fearon, J E Silbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1988
Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cellsR L Stevens, C C Fox, L M Lichtenstein, et al.
Pageof 61

Showing results (381-390 of 604) with videos related to

Sort By:
Pageof 61
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1970
Genetic and cellular factors in the immune response. I. Genetic control of the antibody response to poly Glu52 Lys33 Tyr15 in the inbred rat strains ACI and F344T J Gill, H W Kunz, D J Stechschulte, et al.
Clinical and Experimental Immunology|April 1, 1978
Cutaneous necrotizing venulitis: a sequential analysis of the morphological alterations occurring after mast cell degranulation in a patient with a unique syndromeN A Soter, M C Mihm, H F Dvorak, et al.
The Journal of Biological Chemistry|December 25, 1980
Polydispersity of rat mast cell heparin. Implications for proteoglycan assemblyD D Metcalfe, J A Smith, K F Austen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1983
Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factorA Nicholson-Weller, J P March, S I Rosenfeld, et al.
The Journal of Biological Chemistry|November 15, 1986
Complexes of heparin proteoglycans, chondroitin sulfate E proteoglycans, and [3H]diisopropyl fluorophosphate-binding proteins are exocytosed from activated mouse bone marrow-derived mast cellsW E Serafin, H R Katz, K F Austen, et al.
The New England Journal of Medicine|March 13, 1980
Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticariaN A Soter, S I Wasserman, K F Austen, et al.
The Journal of Experimental Medicine|February 1, 1978
Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparinJ M Weiler, R W Yurt, D T Fearon, et al.
The Journal of Biological Chemistry|February 5, 1986
Inhibition of homogeneous human eosinophil arylsulfatase B by sulfidopeptide leukotrienesP F Weller, E J Corey, K F Austen, et al.
The Journal of Experimental Medicine|November 1, 1979
Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3bM D Kazatchkine, D T Fearon, J E Silbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1988
Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cellsR L Stevens, C C Fox, L M Lichtenstein, et al.
Pageof 61